No annual accounts yet
This company hasn't filed annual accounts with the National Bank yet. As soon as one arrives, the analysis appears here.
What happened to Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials?
What happened at Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Start of the company according to the CBE. KBO
A new publication or filing at Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials? We notify you, reason included.
Follow Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical TrialsEstablishments
Establishment units
Physical locations of this company
Mijlenmeersstraat 90
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →Ziekenhuisvereniging van Brussel - Universitair Verplegingscentrum Jules Bordet
Association Jules Bordet
€ 164,268 revenue · 2025
FONDS ARIANE
European Lung Cancer Working Party
ASSOCIATION PLURIDICIPLINAIRE DES MEDECINS DE L'INSTITUT JULES BORDET
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1013.225.475
- VAT number
- BE 1013.225.475
- Registered office
- Mijlenmeersstraat 90, 1070 Anderlecht
- Names & denominations
- Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials · Oncodistinct
- Enterprise type
- Rechtspersoon
- Legal form
- International non-profit association
- Legal situation
- Normale toestand
- Start date
- 5 September 2024
- Peppol
- Active · Active since 19 Mar 2026
- Activities · NACE
Overige activiteiten op het gebied van menselijke gezondheidszorg, neg